论文部分内容阅读
米非司酮在临床上主要配伍米索前列醇用于抗早孕及终止排卵后的妊娠。美国食品药品管理局(FDA)在2003~2005年间共收到4例使用米非司酮出现细菌感染和脓毒血症死亡的报告,并于2005年发出公众健康通报告诫慎用米非司酮[1]。为了考察米非司酮应用安全性,我们对连续给予米非司酮和?
Mifepristone clinically compatible with misoprostol for early pregnancy and termination of pregnancy after ovulation. The U.S. Food and Drug Administration (FDA) received a total of 4 reports of bacterial infections and sepsis deaths with mifepristone between 2003 and 2005. In 2005, the FDA issued a public health circular warning against the use of mifepristone [1]. In order to investigate the safety of mifepristone, we continue to give mifepristone and?